Concert Pharmaceuticals (CNCE) PT Lowered to $18 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities analyst Didei Yang lowered the price target on Concert Pharmaceuticals (NASDAQ: CNCE) to $18.00 (from $29.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
